How to manufacture a disease

posted by
December 23, 2010
In These Times
by Terry J. Allen  
Posted in Commentary, PND Commentary

"After the FDA approves a new drug, it rarely faces follow-up studies that might reveal serious and possibly fatal side effects. Some dangers remain hidden for years until an accumulation of disasters sparks lawsuits. Faced with litigation, corporations must cough up data — and sometimes choke on it. A suit against drug maker Wyeth freed 1,500 documents that yielded 'unprecedented insights into how pharmaceutical companies promote drugs,' wrote Adrianne Fugh-Berman in a September study in PLoS Medicine." (12/23/10)  

Our Sponsors